Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | -74% | -100% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 50% | 50% | 36.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -3,435,769.2% | -1,489,600% | -1,004.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -3,431.2% | -1,488% | -994.1% |
| EPS Diluted | -0.43 | -0 | -0.001 | -1.02 |
| % Growth | -143,233.3% | 40% | 100% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |